Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model

The most severe side effect of prolonged MTX treatment is hepatotoxicity. The aim of this study is to investigate the effect of lactulose treatment on MTX-induced hepatotoxicity in a rat model. Twenty-four male rats were included in the study. Sixteen rats were given a single dose of 20 mg/kg MTX to...

Full description

Saved in:
Bibliographic Details
Main Authors: Banu Taskin, Mümin Alper Erdoğan, Gürkan Yiğittürk, Damla Günenç, Oytun Erbaş
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2017/7942531
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558377538945024
author Banu Taskin
Mümin Alper Erdoğan
Gürkan Yiğittürk
Damla Günenç
Oytun Erbaş
author_facet Banu Taskin
Mümin Alper Erdoğan
Gürkan Yiğittürk
Damla Günenç
Oytun Erbaş
author_sort Banu Taskin
collection DOAJ
description The most severe side effect of prolonged MTX treatment is hepatotoxicity. The aim of this study is to investigate the effect of lactulose treatment on MTX-induced hepatotoxicity in a rat model. Twenty-four male rats were included in the study. Sixteen rats were given a single dose of 20 mg/kg MTX to induce liver injury. Eight rats were given no drugs. 16 MTX-given rats were divided into two equal groups. Group 1 subjects were given lactulose 5 g/kg/day, and group 2 subjects were given saline 1 ml/kg/day for 10 days. The rats were then sacrificed to harvest blood and liver tissue samples in order to determine blood and tissue MDA, serum ALT, plasma TNF-α, TGF-β, and PTX3 levels. Histological specimens were examined via light microscopy. Exposure to MTX caused structural and functional hepatotoxicity, as evidenced by relatively worse histopathological scores and increased biochemical marker levels. Lactulose treatment significantly reduced the liver enzyme ALT, plasma TNF-α, TGF-β, PTX3, and MDA levels and also decreased histological changes in the liver tissue with MTX-induced hepatotoxicity in the rat model. We suggest that lactulose has anti-inflammatory and antifibrotic effects on an MTX-induced liver injury model. These effects can be due to the impact of intestinal microbiome.
format Article
id doaj-art-36027a88187249f4b759c03c020a215e
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-36027a88187249f4b759c03c020a215e2025-02-03T01:32:33ZengWileyGastroenterology Research and Practice1687-61211687-630X2017-01-01201710.1155/2017/79425317942531Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury ModelBanu Taskin0Mümin Alper Erdoğan1Gürkan Yiğittürk2Damla Günenç3Oytun Erbaş4Faculty of Medicine, Department of Dermatology, Istanbul Bilim University, Istanbul, TurkeyFaculty of Medicine, Department of Physiology, Ege University, Izmir, TurkeyFaculty of Medicine, Department of Histology and Embryology, Ege University, Izmir, TurkeyFaculty of Medicine, Department of Internal Medicine, Ege University, Izmir, TurkeyFaculty of Medicine, Department of Physiology, Istanbul Bilim University, Istanbul, TurkeyThe most severe side effect of prolonged MTX treatment is hepatotoxicity. The aim of this study is to investigate the effect of lactulose treatment on MTX-induced hepatotoxicity in a rat model. Twenty-four male rats were included in the study. Sixteen rats were given a single dose of 20 mg/kg MTX to induce liver injury. Eight rats were given no drugs. 16 MTX-given rats were divided into two equal groups. Group 1 subjects were given lactulose 5 g/kg/day, and group 2 subjects were given saline 1 ml/kg/day for 10 days. The rats were then sacrificed to harvest blood and liver tissue samples in order to determine blood and tissue MDA, serum ALT, plasma TNF-α, TGF-β, and PTX3 levels. Histological specimens were examined via light microscopy. Exposure to MTX caused structural and functional hepatotoxicity, as evidenced by relatively worse histopathological scores and increased biochemical marker levels. Lactulose treatment significantly reduced the liver enzyme ALT, plasma TNF-α, TGF-β, PTX3, and MDA levels and also decreased histological changes in the liver tissue with MTX-induced hepatotoxicity in the rat model. We suggest that lactulose has anti-inflammatory and antifibrotic effects on an MTX-induced liver injury model. These effects can be due to the impact of intestinal microbiome.http://dx.doi.org/10.1155/2017/7942531
spellingShingle Banu Taskin
Mümin Alper Erdoğan
Gürkan Yiğittürk
Damla Günenç
Oytun Erbaş
Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
Gastroenterology Research and Practice
title Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
title_full Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
title_fullStr Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
title_full_unstemmed Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
title_short Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
title_sort antifibrotic effect of lactulose on a methotrexate induced liver injury model
url http://dx.doi.org/10.1155/2017/7942531
work_keys_str_mv AT banutaskin antifibroticeffectoflactuloseonamethotrexateinducedliverinjurymodel
AT muminalpererdogan antifibroticeffectoflactuloseonamethotrexateinducedliverinjurymodel
AT gurkanyigitturk antifibroticeffectoflactuloseonamethotrexateinducedliverinjurymodel
AT damlagunenc antifibroticeffectoflactuloseonamethotrexateinducedliverinjurymodel
AT oytunerbas antifibroticeffectoflactuloseonamethotrexateinducedliverinjurymodel